There is no new virus of any kind affecting women. A "cancerous revolution" has emerged, stemming from the interplay between biological diversity, hormonal factors, and environmental variables—a process that drives cultural and cellular shifts within populations. Materials and Methods: The study involved 80 female volunteers, aged 30 to 60, who were assigned to the patient group (P) and divided into four subgroups (G1, G2, G3, and G4; 20 volunteers per subgroup). These individuals were diagnosed by a specialist physician. A control group consisting of healthy female volunteers was also included. Blood samples were collected at the Kirkuk Oncology Center in Kirkuk, Iraq, between October 2025 and January 2026. Results: Analysis of the blood samples using the ELISA test revealed a significant increase in Interleukin-17 (IL-17).